Delivery system for biological component

Details Delivery system for biological component Delivery system for biological component

2011-08-30

2011-08-30

Hanley, Susan (Department: 1653)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C424S093450, C424S093400, C424S464000, C424S093460, C424S093500, C424S093510, C435S252100, C435S252900

Reexamination Certificate

active

08007777

ABSTRACT:
The invention relates to a controlled release formulation for a probiotic. The formulation contains a hydrophilic agent, an electrolytic agent and a polysaccharide and is in the form of a monolithic tablet for oral delivery to the intestinal system. The probiotic can be lactic acid bacteria.

REFERENCES:
patent: 3072528 (1963-01-01), Kludas
patent: 4264573 (1981-04-01), Powell
patent: 4542020 (1985-09-01), Jackson
patent: 4755180 (1988-07-01), Ayer
patent: 4777033 (1988-10-01), Ikura
patent: 4806368 (1989-02-01), Reddy
patent: 4966768 (1990-10-01), Michelucci
patent: 5194172 (1993-03-01), Taneri
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5288507 (1994-02-01), Sims et al.
patent: 5419917 (1995-05-01), Chen
patent: 5531681 (1996-07-01), Walton et al.
patent: 5789446 (1998-08-01), Uchiyama et al.
patent: 5830884 (1998-11-01), Kasica et al.
patent: 6090411 (2000-07-01), Pillay et al.
patent: 6127561 (2000-10-01), Jeromin
patent: 6241983 (2001-06-01), Paul et al.
patent: 6337091 (2002-01-01), Kim et al.
patent: 6365148 (2002-04-01), Kim et al.
patent: 6375994 (2002-04-01), Paul
patent: 6403120 (2002-06-01), Sherman et al.
patent: 6413494 (2002-07-01), Lee et al.
patent: 6458384 (2002-10-01), Jaenicke et al.
patent: 6479051 (2002-11-01), Bruce et al.
patent: 6517868 (2003-02-01), Fassihi et al.
patent: 6777000 (2004-08-01), Ni et al.
patent: 6936275 (2005-08-01), Fassihi
patent: 7122370 (2006-10-01), Porubcan
patent: 7201923 (2007-04-01), van Lengerich
patent: 7229642 (2007-06-01), Fassihi
patent: 7498310 (2009-03-01), Schonrock et al.
patent: 2001/0005513 (2001-06-01), Haan et al.
patent: 2002/0010127 (2002-01-01), Oshlack
patent: 2002/0107495 (2002-08-01), Chen et al.
patent: 2003/0021841 (2003-01-01), Matharu et al.
patent: 09110705 (1997-04-01), None
patent: 9748386 (1997-12-01), None
patent: WO 9952507 (1999-10-01), None
patent: 02094424 (2002-11-01), None
Pillay et al. J. Controlled Release (2000) 67:67-78.
Chen et al., Chemical Physical, and Baking Properties of Apple Fiber Compared with Wheat and Oat Bran, Cereal Chemistry, 1988, vol. 65, No. 3, pp. 244-247.
Maggi et al., “Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration,” Eu. J. Pharm Biopharm., 2000, vol. 50, No. 3, p. 389-395.
Raffalt, J.D. et al., Proceedings for the international symposium on controlled release bioactive materials, 1999, No. 26, p. 865-6.
curehunter.com/public/keywordSummaryCO09683-witepsol.do, downloaded May 7, 2010.
Webster's II New Riverside University Dictionary (1997) (Houghton-Mifflin: Boston, MA) p. 1175.
www.treetopingredients.com/ applefiber.asp (1 of 3)11/10/210.
Schilling et al. European J Pharma. Biopharma. (2010) 74:352-361.

Affiliated with

Also associated with

Rating

Delivery system for biological component does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Delivery system for biological component, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery system for biological component will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2634179